BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12883390)

  • 21. Trends in subsite distribution of colorectal cancers and polyps from the Vaud Cancer Registry.
    Levi F; Randimbison L; La Vecchia C
    Cancer; 1993 Jul; 72(1):46-50. PubMed ID: 8508429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpreting the international trends in testicular seminoma and nonseminoma incidence.
    Bray F; Ferlay J; Devesa SS; McGlynn KA; Møller H
    Nat Clin Pract Urol; 2006 Oct; 3(10):532-43. PubMed ID: 17031378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer: a prospective population- and register-based study on Norwegian males born between 1967 and 1995.
    Wanderås EH; Grotmol T; Fosså SD; Tretli S
    Cancer Causes Control; 1998 Oct; 9(5):475-86. PubMed ID: 9934714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of anal carcinoma in Vaud, Switzerland, 1979-2001.
    Levi F; Te VC; Randimbison L; La Vecchia C
    Eur J Cancer Prev; 2004 Jun; 13(3):213-5. PubMed ID: 15167221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testicular cancer in Luxembourg: incidence and outcome in relation to the different histo-pathological types (1980-2004).
    Scheiden R; Hein T; Wagener C; Kieffer N; Lamy S; Capesius C
    Bull Soc Sci Med Grand Duche Luxemb; 2008; (4):521-39. PubMed ID: 19024372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of second cancer after testicular cancer in Vaud and Neuchâtel, Switzerland.
    Levi F; Randimbison L; Te VC; Erler G; La Vecchia C
    Ann Oncol; 1999 Sep; 10(9):1129-30. PubMed ID: 10572616
    [No Abstract]   [Full Text] [Related]  

  • 27. Trends in incidence of various morphologies of malignant melanoma in Vaud and Neuchatel, Switzerland.
    Levi F; Te VC; Randimbison L; La Vecchia C
    Melanoma Res; 2005 Feb; 15(1):73-5. PubMed ID: 15714124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Markedly increased incidence and improved survival of testicular cancer in the Netherlands.
    Verhoeven RH; Karim-Kos HE; Coebergh JW; Brink M; Horenblas S; de Wit R; Kiemeney BA
    Acta Oncol; 2014 Mar; 53(3):342-50. PubMed ID: 23992111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing incidence of testicular cancer--birth cohort effects.
    Ekbom A; Akre O
    APMIS; 1998 Jan; 106(1):225-9; discussion 229-31. PubMed ID: 9524583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testicular cancer in Geneva, Switzerland, 1970-2012: incidence trends, survival and risk of second cancer.
    Schaffar R; Pant S; Bouchardy C; Schubert H; Rapiti E
    BMC Urol; 2019 Jul; 19(1):64. PubMed ID: 31291913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in incidence of testicular cancer in Norway 1955-1992.
    Wanderås EH; Tretli S; Fosså SD
    Eur J Cancer; 1995 Nov; 31A(12):2044-8. PubMed ID: 8562163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Geographic clustering of testicular cancer incidence in the northern part of The Netherlands.
    Sonneveld DJ; Schaapveld M; Sleijfer DT; Meerman GJ; van der Graaf WT; Sijmons RH; Koops HS; Hoekstra HJ
    Br J Cancer; 1999 Dec; 81(7):1262-7. PubMed ID: 10584892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality.
    Bray F; Richiardi L; Ekbom A; Pukkala E; Cuninkova M; Møller H
    Int J Cancer; 2006 Jun; 118(12):3099-111. PubMed ID: 16395710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frailty modelling of testicular cancer incidence using Scandinavian data.
    Moger TA; Aalen OO; Halvorsen TO; Storm HH; Tretli S
    Biostatistics; 2004 Jan; 5(1):1-14. PubMed ID: 14744824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center.
    Che M; Tamboli P; Ro JY; Park DS; Ro JS; Amato RJ; Ayala AG
    Cancer; 2002 Sep; 95(6):1228-33. PubMed ID: 12216089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends of in situ carcinoma of the breast in Vaud, Switzerland.
    Levi F; Te VC; Randimbison L; La Vecchia C
    Eur J Cancer; 1997 May; 33(6):903-6. PubMed ID: 9291813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testicular cancer.
    Forman D; Møller H
    Cancer Surv; 1994; 19-20():323-41. PubMed ID: 7534631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testicular cancer in Europe and the USA: survival still rising among older patients.
    Verhoeven RHA; Gondos A; Janssen-Heijnen MLG; Saum KU; Brewster DH; Holleczek B; Crocetti E; Rosso S; Hakulinen T; Aareleid T; Brenner H;
    Ann Oncol; 2013 Feb; 24(2):508-513. PubMed ID: 23110807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in cancer incidence and mortality in Vaud, Switzerland, 1974-1993.
    Levi F; Te VC; Randimbison L; La Vecchia C
    Ann Oncol; 1996 Jul; 7(5):497-504. PubMed ID: 8839905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for testicular cancer--differences between pure non-seminoma and mixed seminoma/non-seminoma?
    Aschim EL; Haugen TB; Tretli S; Daltveit AK; Grotmol T
    Int J Androl; 2006 Aug; 29(4):458-67. PubMed ID: 16487404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.